|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||||||||||
| Receivables, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long-term assets | ||||||||||||||||||||
| Property and equipment - net | ||||||||||||||||||||
| Right of use asset – operating lease | ||||||||||||||||||||
| Security deposits | ||||||||||||||||||||
| Total long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Subscription payable | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes payable | ||||||||||||||||||||
| Operating lease liability - current | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accrued dividends | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities | ||||||||||||||||||||
| Operating lease liability - non-current | ||||||||||||||||||||
| Deferred Equity Financing | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at June 30, 2026 and December 31, 2025 (Liquidation preference $340,050 and $340,050, respectively) | ||||||||||||||||||||
| Series A convertible preferred stock | ||||||||||||||||||||
| Total series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at June 30, 2026 and December 31, 2025 (Liquidation preference $340,050 and $340,050, respectively) | ||||||||||||||||||||
| Common stock, $.001 par value, 500,000,000 shares authorized; 229,960,003 and 229,580,642 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
